PH11892A - Oxytetracycline solution farenteral,peroral and local administration - Google Patents

Oxytetracycline solution farenteral,peroral and local administration

Info

Publication number
PH11892A
PH11892A PH16812A PH16812A PH11892A PH 11892 A PH11892 A PH 11892A PH 16812 A PH16812 A PH 16812A PH 16812 A PH16812 A PH 16812A PH 11892 A PH11892 A PH 11892A
Authority
PH
Philippines
Prior art keywords
farenteral
peroral
local administration
oxytetracycline solution
oxytetracycline
Prior art date
Application number
PH16812A
Other languages
English (en)
Inventor
H Ghilardi
K Atasoy
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH11892A publication Critical patent/PH11892A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH16812A 1974-02-19 1975-02-17 Oxytetracycline solution farenteral,peroral and local administration PH11892A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH227674 1974-02-19

Publications (1)

Publication Number Publication Date
PH11892A true PH11892A (en) 1978-08-29

Family

ID=4229973

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16812A PH11892A (en) 1974-02-19 1975-02-17 Oxytetracycline solution farenteral,peroral and local administration

Country Status (17)

Country Link
US (1) US4020162A (fr)
JP (1) JPS50129724A (fr)
AT (1) AT336793B (fr)
BE (1) BE825656A (fr)
CA (1) CA1052270A (fr)
DE (1) DE2506579A1 (fr)
DK (1) DK138974B (fr)
ES (1) ES434805A1 (fr)
FR (1) FR2261011B1 (fr)
GB (1) GB1494558A (fr)
IE (1) IE40663B1 (fr)
LU (1) LU71862A1 (fr)
MX (1) MX3044E (fr)
NL (1) NL7501248A (fr)
PH (1) PH11892A (fr)
SE (1) SE434457B (fr)
ZA (1) ZA751016B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE3580140D1 (de) * 1984-03-14 1990-11-22 Jerome Corbiere Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
JPS61130228A (ja) * 1984-11-29 1986-06-18 Sunstar Inc ミノサイクリンを安定に配合した組成物
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5075295A (en) * 1989-12-12 1991-12-24 Boehringer Ingelheim Animal Health, Inc. Novel oxytetracycline compositions
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2006130600A1 (fr) * 2005-05-31 2006-12-07 Warsaw Orthopedic, Inc. Compositions et methodes de traitement de la douleur
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) * 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US9244060B2 (en) * 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
AU2010228926B2 (en) 2009-03-26 2015-12-10 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Also Published As

Publication number Publication date
CA1052270A (fr) 1979-04-10
ES434805A1 (es) 1976-12-01
DK138974B (da) 1978-11-27
FR2261011B1 (fr) 1978-07-21
SE434457B (sv) 1984-07-30
GB1494558A (en) 1977-12-07
ZA751016B (en) 1976-01-28
AU7830775A (en) 1976-08-19
IE40663B1 (en) 1979-07-18
DE2506579A1 (de) 1975-08-21
US4020162A (en) 1977-04-26
ATA119375A (de) 1976-09-15
DK138974C (fr) 1979-05-07
IE40663L (en) 1975-08-19
MX3044E (es) 1980-03-04
BE825656A (fr) 1975-08-18
DK4375A (fr) 1975-10-20
NL7501248A (nl) 1975-08-21
FR2261011A1 (fr) 1975-09-12
LU71862A1 (fr) 1975-12-09
JPS50129724A (fr) 1975-10-14
AT336793B (de) 1977-05-25

Similar Documents

Publication Publication Date Title
PH11892A (en) Oxytetracycline solution farenteral,peroral and local administration
IL47445A (en) Pyridazinyl benzimidazoles, their preparation and pharmaceutical compositions containing them
IL48592A (en) 1-substituted-4-benzypiperidine derivatives,their preparation and pharmaceutical composistions comprising them
IL47625A (en) 4-heterocyclyl-6,7-dialkoxyquin-azoline derivatives and pharmaceutical compositions containing them
ZA755614B (en) 1,3,4-trisubstituted-4-arylpiperidines and their preparation
ZA75472B (en) Medicament carrier
IE41662L (en) Androstane derivatives.
GB1517973A (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
NZ178313A (en) Certain amines, and pharmaceutical compositions containingthem
ZA754042B (en) 9-thia- or oxothia and dioxothia-11,12-seco-prostaglandin
ZA755420B (en) W-nor-cycloalkyl-13, 14-dehydroprostaglandins and process for their preparation
PH12712A (en) Substituted s-alkylphenylisotrioureas,and their use as medicaments
ZA741813B (en) Perforator
IE40565L (en) Oxytetracycline solution
AU8397675A (en) Insulin, analogs and derivatives thereof
IL46559A0 (en) Teleprinter
NZ179530A (en) 9-aminoalk(en)yl-9,10-dihydro9,10-methanoanthracenes and pharmaceutical compositions
IL47487A (en) 9-thia-or oxothia-and diocxothia-11,12-seco and 11-nor-11,12-seco-prostaglandins
IE41381L (en) Preparation of n,n-dialkylxlylenediamines
ZA751883B (en) New 1-aryl-uracils, their production and their medicinal use
EG12408A (en) O,s-dialkyl o-sulfonyloxyphenyl phosphoro-thiolates and phosphorodithiates
ZA752472B (en) 3,4-dicarboxycephalosporins and derivatives
IL46294A0 (en) 2-halogeno-5-phenyl-3h-1,4-benzodiazepines and their preparation
IL47263A (en) 3s-methyl-7-nitro-5-phenyl-2h-1,4-benzodiazepine-2-ones, their manufacture and pharmaceutical compositions containinthem
ZA757295B (en) Hypolipemising drug